VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AMN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AMNAMN Healthcare Services, Inc.
$38.10$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAMNFinancials

AMN Healthcare Services, Inc. (AMN) Income Statement

26Y historyFree accessUpdated daily

Revenue climbed 13.0% year-over-year to $717.3M in 2026Q3 with operating margin of 7.0% and diluted EPS of $0.83, though SG&A consuming roughly 20.8% of revenue continues to limit operating leverage.

Income StatementBalance SheetCash FlowRatios

AMN Income Statement

Annual statement

AMN Income Statement

AMN Healthcare Services, Inc. (AMN) annual income statement — 26-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Sales/Revenue3.52B2.73B2.98B3.79B5.24B3.98B2.39B2.22B2.14B1.99B1.9B1.46B1.04B1.01B953.95M887.47M689.22M759.79M1.22B1.16B1.08B705.84M629.02M714.21M775.68M517.79M230.77M
Revenue Growth %29.45%-8.49%-21.26%-27.73%31.6%66.45%7.72%4.03%7.42%4.53%30.02%41.22%2.39%6.07%7.49%28.76%-9.29%-37.58%4.57%7.61%53.25%12.21%-11.93%-7.93%49.81%124.38%-
Cost of Goods Sold2.52B1.96B2.06B2.54B3.53B2.67B1.6B1.48B1.44B1.34B1.28B993.7M719.91M714.54M683.55M638.15M497.69M555.37M900.21M860.86M792.41M535.61M484.65M552.05M586.9M388.28M170.61M
COGS % of Revenue-71.65%69.19%67.02%67.26%67.13%66.92%66.54%67.4%67.59%67.42%67.92%69.49%70.62%71.66%71.91%72.21%73.1%73.96%73.96%73.26%75.88%77.05%77.3%75.66%74.99%73.93%
Gross Profit998.97M774.06M919.38M1.25B1.72B1.31B791.78M743.47M696.38M644.42M619.72M469.36M316.12M297.28M270.4M249.32M191.53M204.42M316.99M303.17M289.29M170.24M144.36M162.16M188.78M129.51M60.16M
Gross Margin %28.4%28.35%30.81%32.98%32.74%32.87%33.08%33.46%32.6%32.41%32.58%32.08%30.51%29.38%28.34%28.09%27.79%26.9%26.04%26.04%26.74%24.12%22.95%22.7%24.34%25.01%26.07%
Gross Profit Growth %--15.81%-26.43%-27.21%31.08%65.4%6.5%6.76%8.06%3.98%32.04%48.48%6.34%9.94%8.45%30.18%-6.31%-35.51%4.56%4.8%69.93%17.92%-10.97%-14.1%45.77%115.28%-
Operating Expenses796.21M740.89M1.02B911.15M1.07B831.6M642.51M566.55M493.56M431.98M428.09M340.48M248.21M231.78M217.06M211.67M183.21M171.05M490.21M230.82M215.82M123.5M108.02M98.19M102.52M113.03M57.91M
OpEx % of Revenue-27.13%34.25%24.05%20.4%20.87%26.84%25.5%23.11%21.72%22.5%23.27%23.96%22.91%22.75%23.85%26.58%22.51%40.27%19.83%19.95%17.5%17.17%13.75%13.22%21.83%25.09%
Selling, General & Admin667.2M593.02M632.49M756.24M936.58M730.45M549.75M508.03M452.32M399.7M398.47M319.53M232.22M218.23M202.9M195.35M168.13M157.24M230.66M218.25M205.5M117.33M102.19M93.37M98.68M103.36M54.61M
SG&A % of Revenue-21.72%21.2%19.96%17.86%18.33%22.97%22.86%21.18%20.1%20.95%21.84%22.41%21.57%21.27%22.01%24.39%20.7%18.95%18.75%19%16.62%16.25%13.07%12.72%19.96%23.66%
Research & Development000000000000000000000000000
R&D % of Revenue---------------------------
Other Operating Expenses4M147.87M389.56M154.91M133.01M101.15M92.77M58.52M41.24M32.28M29.62M20.95M15.99M13.54M14.15M16.32M15.08M13.81M14.44M12.57M10.32M6.18M5.84M4.82M3.84M9.67M3.3M
Operating Income202.76M33.17M-102.67M338.43M647.1M478M149.26M176.91M202.83M212.44M191.63M128.88M67.9M65.5M53.34M37.65M-42.52M-153.61M71.89M72.34M73.46M46.73M36.34M63.96M86.27M16.48M2.25M
Operating Margin %5.76%1.21%-3.44%8.93%12.34%12%6.24%7.96%9.5%10.68%10.07%8.81%6.55%6.47%5.59%4.24%-6.17%-20.22%5.91%6.21%6.79%6.62%5.78%8.96%11.12%3.18%0.97%
Operating Income Growth %-132.3%-130.34%-47.7%35.38%220.23%-15.63%-12.78%-4.52%10.86%48.69%89.8%3.67%22.8%41.69%188.54%72.32%-313.66%-0.62%-1.53%57.21%28.59%-43.19%-25.85%423.52%633.01%-
EBITDA341.56M189.77M71.11M499.36M784.21M581.7M243.45M235.44M244.06M244.72M221.25M149.83M83.9M79.05M67.49M53.97M-27.43M-139.8M86.33M84.02M83.79M52.91M42.18M68.78M90.1M24.19M5.55M
EBITDA Margin %9.71%6.95%2.38%13.18%14.96%14.6%10.17%10.6%11.43%12.31%11.63%10.24%8.1%7.81%7.08%6.08%-3.98%-18.4%7.09%7.22%7.75%7.5%6.71%9.63%11.62%4.67%2.41%
EBITDA Growth %336.41%166.88%-85.76%-36.32%34.82%138.94%3.41%-3.54%-0.27%10.61%47.67%78.59%6.13%17.12%25.05%296.73%80.38%-261.93%2.76%0.27%58.36%25.45%-38.68%-23.66%272.47%335.8%-
D&A (Non-Cash Add-back)138.81M156.6M173.78M160.93M137.11M103.7M94.19M58.52M41.24M32.28M29.62M20.95M15.99M13.54M14.15M16.32M15.08M13.81M14.44M11.67M10.32M6.18M5.84M4.82M3.84M7.71M3.3M
EBIT202.71M-55.47M-102.67M338.43M647.1M478M149.26M176.91M202.83M212.44M191.63M128.88M64.79M65.5M43.53M37.65M-43.78M-153.61M71.89M72.34M73.46M45.53M36.34M63.96M86.27M16.48M2.25M
Net Interest Income-33.33M-45.59M-69.9M-54.14M-40.4M-34.08M-57.74M-28.43M-16.14M-19.68M-15.46M-7.79M-9.24M-9.66M-26.02M-23.73M-19.76M-11.96M-10.69M00000000
Interest Income00000000000000009K0000000000
Interest Expense33.33M45.59M69.9M54.14M40.4M34.08M57.74M28.43M16.14M19.68M15.46M7.79M9.24M9.66M26.02M23.73M19.77M11.96M10.69M12.46M16.7M9.56M8.44M2.3M000
Other Income/Expense-33.37M-134.23M-69.9M-54.14M-40.4M-34.08M-57.74M-28.43M-16.14M-19.68M-15.46M-7.79M-9.24M-9.66M-26.02M-23.73M-19.77M-11.96M-10.69M-11.56M-16.7M-9.56M-8.44M-2.3M343K-13.93M-10.01M
Pretax Income169.38M-101.06M-172.57M284.29M606.7M443.92M91.52M148.49M186.69M192.76M176.17M121.09M58.67M55.84M27.32M13.92M-62.29M-165.56M61.2M60.78M56.77M37.16M27.9M61.66M86.61M2.54M-7.76M
Pretax Margin %4.82%-3.7%-5.78%7.5%11.57%11.14%3.82%6.68%8.74%9.69%9.26%8.28%5.66%5.52%2.86%1.57%-9.04%-21.79%5.03%5.22%5.25%5.27%4.44%8.63%11.17%0.49%-3.36%
Income Tax60.36M-5.36M-25.59M73.61M162.65M116.53M20.86M34.5M44.94M60.2M70.33M39.2M25.45M22.9M11.01M8.9M-10.3M-43.39M26.85M24.25M21.68M14.93M10.55M23.87M34.25M1.48M-2.56M
Effective Tax Rate %35.64%5.3%14.83%25.89%26.81%26.25%22.79%23.23%24.07%31.23%39.92%32.37%43.38%41.02%40.3%63.97%16.53%26.21%43.86%39.9%38.18%40.17%37.83%38.71%39.55%58%33%
Net Income109.02M-95.7M-146.98M210.68M444.05M327.39M70.67M113.99M141.74M132.56M105.84M81.89M33.22M32.93M17.14M-26.27M-51.99M-122.18M34.36M36.53M35.09M22.23M17.35M37.79M52.36M-4.39M-5.2M
Net Margin %3.1%-3.5%-4.93%5.56%8.47%8.22%2.95%5.13%6.64%6.67%5.56%5.6%3.21%3.25%1.8%-2.96%-7.54%-16.08%2.82%3.14%3.24%3.15%2.76%5.29%6.75%-0.85%-2.25%
Net Income Growth %139.57%34.89%-169.76%-52.56%35.63%363.3%-38.01%-19.58%6.93%25.25%29.24%146.53%0.86%92.19%165.24%49.48%57.45%-455.61%-5.95%4.11%57.83%28.18%-54.1%-27.82%1293.71%15.62%-
Net Income (Continuing)109.02M-95.7M-146.98M210.68M444.05M327.39M70.67M113.99M141.74M132.56M105.84M81.89M33.22M32.93M16.31M5.02M-51.99M-122.18M34.36M36.53M35.09M22.23M17.35M37.79M52.36M1.07M-5.2M
Discontinued Operations000000000000000000000000000
Minority Interest000000000000000000000000000
EPS (Diluted)2.71-2.48-3.855.369.906.811.482.402.912.682.151.680.690.690.37-0.57-1.49-3.751.021.041.020.690.550.951.12-0.14-0.23
EPS Growth %138.26%35.58%-171.83%-45.86%45.37%360.14%-38.33%-17.53%8.58%24.65%27.98%143.48%0%86.49%164.91%61.75%60.27%-467.65%-1.92%1.96%47.83%25.45%-42.11%-15.18%900%39.13%-
EPS (Basic)--2.48-3.855.389.966.871.492.442.992.772.211.720.710.720.38-0.66-1.49-3.751.031.061.070.760.611.041.23-0.14-0.23
Diluted Shares Outstanding40.16M38.52M38.19M39.34M44.87M48.05M47.69M47.59M48.67M49.43M49.27M48.84M48.09M47.79M46.71M45.95M34.84M32.62M33.81M34.88M34.5M32.12M31.37M39.78M46.8M30.64M22.5M
Basic Shares Outstanding39.11M38.52M38.19M39.17M44.59M47.69M47.42M46.7M47.37M47.81M47.95M47.52M46.5M45.96M41.63M39.91M34.84M32.62M33.38M34.38M32.66M29.13M28.25M36.46M42.53M30.64M22.5M
Dividend Payout Ratio---------------------------

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Hospital labor demand volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Rebounds After Mid-Cycle Trough

According to reported quarterly figures, AMN's revenue climbed from $634.5M in 2025Q3 to $717.3M in 2026Q3, a 13.0% year-over-year gain that suggests demand has begun to recover from its post-pandemic normalization trough.

The 2026Q3 top-line improvement appears driven by nursing and allied staffing demand, which management attributes to demand strengthening into October. However, the -8.49% trailing decline indicates the rebound is recent and not yet established as a durable trend. Investors should monitor whether sequential growth persists across the next two quarters before treating the recovery as structural.

Gross Margin Recovers Within Narrow Band

Based on EDBL-style reported figures, AMN's gross margin improved to 31.9% in 2026Q3 from 26.1% in 2025Q4, with the trailing range suggesting pricing spreads remain sensitive to clinician pay pressure.

The margin fluctuation across the ten-quarter window indicates that the bill-pay spread is the dominant variable in AMN's gross profit, rather than a fixed structural advantage. The 2026Q3 expansion may reflect favorable mix toward higher-margin Technology and Workforce revenue, though the reported data does not isolate this contribution. Sustained margins above 30% would warrant closer examination of whether pricing power is improving or whether the result is cyclical.

Operating Leverage Remains Constrained

As reported in financial statements, AMN's SG&A of $149.3M in 2026Q3 consumed roughly 20.8% of revenue, leaving operating margin at 7.0%, which suggests overhead remains a meaningful drag on incremental profitability.

Operating income of $50.5M in 2026Q3 versus $8.4M a year earlier reflects some scaling, but SG&A grew broadly in line with revenue, limiting the operating leverage effect. The quarterly operating margin has oscillated between roughly 1% and 8% outside of impairment-affected periods, which may indicate a cost base that has not yet been right-sized to current demand. Continued SG&A discipline will be essential for margin expansion.

EPS Beat Diverges From Net Margin

Based on reported figures, AMN's 2026Q3 diluted EPS of $0.83 contrasts with a trailing net margin still in negative territory, suggesting the headline earnings improvement may rely on items outside core operations.

A $33.4M net income against $50.5M operating income implies meaningful below-the-line charges, including interest expense on elevated leverage. The trailing ROE of -14.2% and Debt/Equity of 1.25 reinforce that earnings have not yet translated into sustained equity value creation. Investors should verify earnings quality against the cash flow statement before extrapolating the quarterly EPS result.

Guidance Cut Tempers Quarterly Optimism

According to management's lowered forward guidance of $655M to $670M, the strong 2026Q3 quarter may not signal sustained top-line momentum, which warrants scrutiny of how durable the demand recovery truly is.

The downward revision in guidance, despite a quarter of positive demand commentary, suggests management is less confident in near-term visibility than the EPS result implies. If labor disruption revenue or other non-recurring contributions drove 2026Q3, the run rate may normalize sharply. Short-sellers would likely point to the persistent negative net margin and elevated leverage as evidence that the recovery is fragile.

AMN — Frequently Asked Questions

Quick answers to the most common questions about buying AMN stock.

What was AMN Healthcare Services, Inc.'s (AMN) revenue in 2025?

For fiscal year 2025, AMN Healthcare Services, Inc. (AMN) reported total revenue of $2.73B. This represents a 1083.2% increase compared to $230.8M in 2000.

Is AMN Healthcare Services, Inc. (AMN) profitable?

AMN Healthcare Services, Inc. (AMN) reported a net loss of $95.7M for the fiscal year ending 2025.

What is AMN Healthcare Services, Inc.'s operating profit margin?

AMN Healthcare Services, Inc. (AMN) reported an operating income of $33.2M, resulting in an operating profit margin of 1.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is AMN Healthcare Services, Inc.'s gross profit and gross margin?

AMN Healthcare Services, Inc. (AMN) generated $774.1M in gross profit for the year, representing a gross profit margin of 28.3%. This demonstrates the company's core pricing power and production efficiency.